Study | Technique | Stage | Size cm | Lesions n | Complete response |
Tokyo Medical University 96, 99–102 | PDT (HpD/Photofrin) | Stage 0 (n = 185) | <2 | 264 | 84.8% |
| | Stage 1 (n = 79) | | | 93% ≤1 cm |
| | | | | 45% >1 cm |
Sutedja 103 | PDT (Photofrin) | Stage 0 (n = 17) | NA | 39 | 72% |
| | Stage 1A/1B (n = 22) | | | Stage 0 100% |
| | | | | Stage 1A/1B 50% |
Cortese 104 | PDT (HpD) | Endobronchial | <2 | 23 | 65% |
| | | | | 88% ≤ 1 cm |
| | | | | 33% > 1 cm |
Kato 105 | PDT (NPe-6) | Stage 0 (n = 23) | <2 | 45 | 84.6% |
| | Stage 1 (n = 22) | | | |
Usuda 106 | PDT (NPe-6) | Stage 0 (n = 37) | <2 | 38 | 94% ≤ 1 cm |
| | Stage 1A (n = 1) | | | 80% > 1 cm |
Deygas 107 | Cryotherapy | Stage 0/1A | NA | 41 | 91% |
van Boxem 108 | EC | Stage 0 (n = 2) | ≤1 | 15 | 80% |
| | Stage 1A (n = 13) | | | |
Vonk Noordegraaf 109 | EC/PDT/YAG laser | Stage 1A | ≤1 | 32 | 97% |
| | | | 26 (EC) | |
| | | | 5 (PDT) | |
| | | | 1 (YAG) | |
Pérol 110 | HDR brachytherapy | Endobronchial | ≤1 | 21 | 75% |
Marsiglia 111 | HDR brachytherapy | Endobronchial | NA | 34 | 85% |
Cavaliere 112 | Nd:YAG laser | Stage 0 | NA | 38 | 63% |